Use of statins and outcome of BCG treatment for bladder cancer.
Hoffmann
Paul
P
Roumeguère
Thierry
T
Schulman
Claude
C
van Velthoven
Roland
R
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D002278:Carcinoma in Situ / Q000628:therapy*; D002784:Cholesterol / Q000097:blood; D016207:Cytokines / Q000187:drug effects / Q000652:urine; D005500:Follow-Up Studies; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D012189:Retrospective Studies; D018417:Th1 Cells / Q000187:drug effects; D018418:Th2 Cells / Q000187:drug effects; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D016207:Cytokines; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol